Description

scription

Diajard 25mg is a prescription medicine manufactured by Highnoon Laboratories, containing Empagliflozin as its active pharmaceutical ingredient. It belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class of medicines, widely used in managing type 2 diabetes mellitus in adults. Empagliflozin works by acting on the kidneys to reduce the reabsorption of glucose into the bloodstream, encouraging its removal through urine instead, which in turn helps lower elevated blood sugar levels. The 25mg strength represents the higher dose within the Diajard range and is generally used once a patient’s treatment has been assessed and confirmed suitable by their physician, often following a period of use on the lower strength. Beyond blood sugar management, this class of medicine is also recognized for its supportive role in certain heart-related and kidney-related conditions, with such use determined individually by the treating doctor. Each pack of Diajard 25mg contains 14 tablets, manufactured under the quality standards maintained by Highnoon Laboratories.

Ingredients

The active ingredient in Diajard 25mg is Empagliflozin, present at a strength of 25 milligrams in each tablet. The formulation also includes standard inactive excipients such as fillers, binding agents, and film-coating materials, which contribute to the tablet’s stability, appearance, and consistent behavior once ingested. These excipients do not carry therapeutic effects themselves but are essential components of the overall tablet formulation.

Dosage Form

Diajard 25mg is supplied as an oral film-coated tablet. Each pack contains 14 tablets, providing a supply suited to ongoing treatment as directed by a prescribing physician. As a solid oral dosage form, it can be taken directly with water without any special preparation required.

Uses

Diajard 25mg is primarily used to improve blood sugar control in adults with type 2 diabetes mellitus, typically as part of a broader management plan that may involve dietary adjustments, physical activity, and in some cases additional diabetes medicines. It is not intended for individuals with type 1 diabetes. Depending on a patient’s overall health profile, doctors may also consider Empagliflozin-based treatment for its recognized benefits related to heart function or kidney health. The specific suitability of Diajard 25mg for any individual should always be assessed and confirmed by a qualified healthcare provider.

How to Use

Diajard 25mg should be taken exactly as directed by a prescribing physician, typically once daily in the morning, with or without food, and preferably at the same time each day to help maintain steady effects. The tablet should be swallowed whole with a glass of water rather than crushed or chewed. Patients should continue to follow any dietary and lifestyle recommendations provided by their doctor while using this medicine, and should never increase or decrease the dose without medical advice. Periodic monitoring of blood sugar levels and kidney function may be recommended by the treating physician throughout the course of treatment.

Side Effects

Diajard 25mg may cause side effects in some individuals, although not everyone will experience them. Commonly reported effects include urinary tract infections, genital yeast infections, increased frequency of urination, and mild dizziness, particularly in cases of low blood pressure. Some patients may also experience symptoms related to mild dehydration or increased thirst. Less commonly, more serious effects such as ketoacidosis with normal blood sugar levels can occur, presenting with nausea, vomiting, abdominal discomfort, or unusual tiredness, which should prompt immediate medical attention. Patients with existing kidney concerns, a tendency toward dehydration, or recurrent urinary infections should discuss these factors with their doctor prior to starting this medicine, particularly given the higher strength involved.

Pregnancy & Breastfeeding

Diajard 25mg should only be used during pregnancy or breastfeeding under the specific guidance of a qualified healthcare provider, as its appropriateness in these situations depends on individual clinical circumstances. Women who are pregnant, planning to conceive, or breastfeeding should inform their doctor before beginning or continuing treatment so that suitable advice can be provided.

Storage Instructions

Diajard 25mg tablets should be stored in a cool, dry place away from direct sunlight and excess humidity, at the room temperature indicated on the product packaging. Tablets should remain within their original blister strip until they are ready to be used, helping to protect them from moisture and light. Keep out of reach of children and pets, and avoid storage in areas with fluctuating temperatures such as bathrooms or vehicle interiors.

FAQS

Q: Is Diajard 25mg stronger than the 10mg version?
Yes, it contains a higher amount of Empagliflozin and is often used once a doctor confirms it is suitable following the lower strength.

Q: Can Diajard 25mg be used alongside other diabetes medicines?
It may be combined with other diabetes treatments as part of a broader management plan, but this should only be done under a doctor’s supervision.

Q: Will Diajard 25mg cause low blood sugar on its own?
Used alone, it carries a relatively low risk of causing low blood sugar, though the risk may increase when combined with certain other diabetes medicines.

Q: How long does it take to see effects from Diajard 25mg?
Blood sugar improvements are typically monitored over several weeks, and consistent use as prescribed is important for effective results.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.